These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28737900)

  • 1. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
    Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU
    J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of Phenylpropanoid Biosynthetic Genes and Their Accumulation in Bitter Melon (Momordica charantia).
    Cuong DM; Kwon SJ; Jeon J; Park YJ; Park JS; Park SU
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29466305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobiotechnology can boost crop production and quality: first evidence from increased plant biomass, fruit yield and phytomedicine content in bitter melon (Momordica charantia).
    Kole C; Kole P; Randunu KM; Choudhary P; Podila R; Ke PC; Rao AM; Marcus RK
    BMC Biotechnol; 2013 Apr; 13():37. PubMed ID: 23622112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.
    Zhou S; Allard PM; Wolfrum C; Ke C; Tang C; Ye Y; Wolfender JL
    Metabolomics; 2019 Jul; 15(8):104. PubMed ID: 31321563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining the bitter melon (momordica charantia l.) seed transcriptome by 454 analysis of non-normalized and normalized cDNA populations for conjugated fatty acid metabolism-related genes.
    Yang P; Li X; Shipp MJ; Shockey JM; Cahoon EB
    BMC Plant Biol; 2010 Nov; 10():250. PubMed ID: 21080948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riboflavin accumulation and characterization of cDNAs encoding lumazine synthase and riboflavin synthase in bitter melon (Momordica charantia).
    Tuan PA; Kim JK; Lee S; Chae SC; Park SU
    J Agric Food Chem; 2012 Dec; 60(48):11980-6. PubMed ID: 23153065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, characterization and quantitative HPLC-DAD analysis of components of charantin from fruits of Momordica charantia.
    Desai S; Tatke P; Mane T; Gabhe S
    Food Chem; 2021 May; 345():128717. PubMed ID: 33307430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the medicinal properties and phytochemical content of bitter melon (Momordica charantia L.) through elicitation with brassinosteroid, ethrel, and carrageenan.
    Mohkami Z; Kheiry A; Sanikhani M; Razavi F; Tavakolizadeh M; Ghorbanpour M
    BMC Plant Biol; 2024 Oct; 24(1):967. PubMed ID: 39407143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bitter Melon (
    Mahwish ; Saeed F; Sultan MT; Riaz A; Ahmed S; Bigiu N; Amarowicz R; Manea R
    Plants (Basel); 2021 Apr; 10(4):. PubMed ID: 33918062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
    Yaldız G; Sekeroglu N; Kulak M; Demirkol G
    Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells.
    Popovich DG; Li L; Zhang W
    Food Chem Toxicol; 2010 Jun; 48(6):1619-26. PubMed ID: 20347917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
    Kenny O; Smyth TJ; Hewage CM; Brunton NP
    Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bitter melon: a panacea for inflammation and cancer.
    Dandawate PR; Subramaniam D; Padhye SB; Anant S
    Chin J Nat Med; 2016 Feb; 14(2):81-100. PubMed ID: 26968675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport in Caco-2 cell monolayers of antidiabetic cucurbitane triterpenoids from Momordica charantia fruits.
    Wu SB; Yue GG; To MH; Keller AC; Lau CB; Kennelly EJ
    Planta Med; 2014 Jul; 80(11):907-11. PubMed ID: 25116119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice.
    Dwijayanti DR; Shimada T; Ishii T; Okuyama T; Ikeya Y; Mukai E; Nishizawa M
    Phytother Res; 2020 Jun; 34(6):1338-1346. PubMed ID: 31845444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.
    Perez JL; Jayaprakasha GK; Patil BS
    Food Chem; 2019 Aug; 288():178-186. PubMed ID: 30902279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
    Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
    Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of triterpene biosynthetic genes from Momordica charantia using RNA-seq analysis.
    Takase S; Kera K; Hirao Y; Hosouchi T; Kotake Y; Nagashima Y; Mannen K; Suzuki H; Kushiro T
    Biosci Biotechnol Biochem; 2019 Feb; 83(2):251-261. PubMed ID: 30317922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.